About us

Diagonal Bio offers a point-of-care testing system for genetic markers that detects pathogens e.g. viruses, bacteria and fungi. The system is approved for use in animals and current target markets are horses, small animals and fish farms. We have extensive expertise in developing markers for eLAMP-testing that can be used on Diagonal’s own system or any other platform using LAMP technology, which creates a potential for licensing and partnerships in the future.

Located in Medicon Village, Lund, Sweden, Diagonal Bio collaborates with leading Key Opinion Leaders (KOLs), clinicians and researchers throughout Sweden and Denmark.

It is also able to leverage the network of expertise in research and life science entrepreneurship that Medicon Village and the Medicon Valley Alliance (MVA) provides.

Diagonal Bio is listed on Nordic SME Sweden under the ticker symbol DIABIO.